Stay updated on T-DM1 & Tucatinib in HER2+ Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the T-DM1 & Tucatinib in HER2+ Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the T-DM1 & Tucatinib in HER2+ Breast Cancer Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    A new revision entry v3.7.0 appears in the record history, replacing the previous v3.6.6. This indicates a version update to the page without changing the underlying study content.
    Difference
    0.1%
    Check dated 2026-09-15T23:55:03.000Z thumbnail image
  4. Check
    33 days ago
    Change Detected
    Summary
    A new revision entry (v3.6.6) was added and the previous revision (v3.6.5) removed in the study record history, indicating an updated version of the page. This is an internal versioning update rather than a substantive change to study data or results.
    Difference
    0.1%
    Check dated 2026-09-01T19:51:14.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    A new revision entry v3.6.5 was added to the study history, and the previous v3.6.4 entry was removed, indicating an update to the record’s revision history.
    Difference
    0.1%
    Check dated 2026-08-11T21:41:15.000Z thumbnail image
  6. Check
    75 days ago
    Change Detected
    Summary
    Record History now shows Revision: v3.6.4 replacing v3.6.3, indicating a small update to the page's versioning.
    Difference
    0.1%
    Check dated 2026-07-21T13:23:10.000Z thumbnail image
  7. Check
    97 days ago
    Change Detected
    Summary
    A new revision entry v3.6.3 was added to the study's revision history, and the older revision v3.6.0 was removed from the list, reflecting an update to the record's version history.
    Difference
    0.1%
    Check dated 2026-06-30T01:52:45.000Z thumbnail image
  8. Check
    111 days ago
    Change Detected
    Summary
    The latest version adds core study metadata sections such as Contacts/Locations, Eligibility, Outcome Measures, Arms and Interventions, Conditions, Study Description, Study Status, and Study Identification. It also notes that recruitment is no longer looking for participants, signaling that the trial is not actively enrolling.
    Difference
    2%
    Check dated 2026-06-15T19:21:19.000Z thumbnail image

Stay in the know with updates to T-DM1 & Tucatinib in HER2+ Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the T-DM1 & Tucatinib in HER2+ Breast Cancer Clinical Trial page.